US2011294186A1PendingUtilityA1

Devices and methods for enrichment and alteration of circulating tumor cells and other particles

Assignee: FUCHS MARTINPriority: Jul 29, 2005Filed: Jan 14, 2011Published: Dec 1, 2011
Est. expiryJul 29, 2025(expired)· nominal 20-yr term from priority
G01N 33/5759G01N 33/5758B01L 3/502707B01L 3/502761B01L 3/502746G01N 2800/52B82Y 10/00B01L 2200/0668G01N 33/54366B01L 2400/0415B82Y 5/00B01L 2400/0406G01N 2333/705G01N 33/56966B01L 2400/086B01L 2400/0409B01L 2400/0487G01N 2333/70589G01N 2333/71
48
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention features devices and methods for detecting, enriching, and analyzing circulating tumor cells and other particles. The invention further features methods of diagnosing a condition, e.g., cancer, in a subject by analyzing a cellular sample from the subject.

Claims

exact text as granted — not AI-modified
1 .- 8 . (canceled) 
     
     
         9 . A microfluidic device comprising: a microfluidic channel, said channel comprising an inlet, an outlet and a micro-corrugated surface, wherein at least one surface of said channel comprises at least one capture moiety that selectively captures a first cell from a cellular sample. 
     
     
         10 . The device of  claim 9 , wherein the at least one capture moiety is an antibody. 
     
     
         11 . The device of  claim 10 , wherein the antibody is an anti-EpCAM antibody. 
     
     
         12 . The device of  claim 9 , wherein the at least one surface comprising a capture moiety is the micro-corrugated surface. 
     
     
         13 . The device of  claim 9 , wherein the micro-corrugated surface is the top surface of the channel. 
     
     
         14 . The device of  claim 9 , wherein the device is configured to retain at least 50% of the first cells present in the cellular sample. 
     
     
         15 . The device of  claim 9 , wherein the device is configured to retain at least 80% of the first cells present in the cellular sample. 
     
     
         16 . The device of  claim 9 , wherein the device is configured for a flow rate of up to 6 mL/hour. 
     
     
         17 . The device of  claim 15 , wherein the device is configured for a flow rate of up to 6 mL/hour. 
     
     
         18 . The device of  claim 9 , wherein at least part of the device is transparent. 
     
     
         19 . The device of  claim 9 , further comprising an imaging device. 
     
     
         20 . The device of  claim 19 , wherein said imaging device is a microscope or spectrometer. 
     
     
         21 . A microfluidic device for the capture of a target cell, comprising: a microfluidic channel comprising an inlet, an outlet, a first array comprising at least one obstacle and a second array comprising at least one obstacle, wherein the obstacles of the first array and the second array are micro-corrugations and wherein at least one surface of said channel comprises at least one capture moiety that selectively captures a first cell from a cellular sample. 
     
     
         22 . The device of  claim 21 , wherein the at least one obstacle in said first array is offset by less than half of the period of the at least one obstacle in the second array. 
     
     
         23 . The device of  claim 21 , wherein the at least one obstacle in the first array is not aligned with the at least one obstacle in the second array. 
     
     
         24 . The device of  claim 21 , wherein the at least one capture moiety is an antibody. 
     
     
         25 . The device of  claim 24 , wherein the antibody is an anti-EpCAM antibody. 
     
     
         26 . The device of  claim 21 , wherein the at least one surface comprising a capture moiety is the micro-corrugated surface. 
     
     
         27 . The device of  claim 21 , wherein the micro-corrugated surface is the top surface of the channel. 
     
     
         28 . The device of  claim 21 , wherein the device is configured to retain at least 50% of the first cells present in the cellular sample. 
     
     
         29 . The device of  claim 21 , wherein the device is configured to retain at least 80% of the first cells present in the cellular sample. 
     
     
         30 . The device of  claim 21 , wherein the device is configured for a flow rate of up to 6 mL/hour. 
     
     
         31 . The device of  claim 29 , wherein the device is configured for a flow rate of up to 6 mL/hour. 
     
     
         32 . The device of  claim 21 , wherein at least part of the device is transparent. 
     
     
         33 . A method for capturing particles in a fluid flowed through a microfluidic channel, comprising:
 flowing the fluid comprising the particles through the microfluidic channel, said channel comprising a micro-corrugated surface;   contacting one or more or the particles on a capture moiety disposed on at least one surface of the microfluidic channel; and   capturing one or more of the particles contacting the capture moiety.   
     
     
         34 . The method of  claim 33 , wherein the at least one surface comprising a capture moiety is the micro-corrugated surface. 
     
     
         35 . The method of  claim 33 , wherein the particles are cancer cells. 
     
     
         36 . The method of  claim 33 , wherein the capture moiety is an antibody.

Join the waitlist — get patent alerts

Track US2011294186A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.